MENU
RPTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Repare Therapeutics (RPTX) Ownership - Who owns Repare Therapeutics?
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more
Profile
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
63.91M
P/E Ratio
N/A
Total Cash
152.79M
Projected Growth
N/A
Total Debt
1.93M
Revenue
53.48M
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash/Share
3.56
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
RPTX
Capitalization
63.9M
P/E Ratio
N/A
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash
153M
Total Cash/Share
3.56
Total Debt
1.93M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
53.5M
ROE
N/A
Book Value
151M
P/B Ratio
0.51
Cash Flow
N/A
Earnings
-2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
487M
Current Ratio
6.77
Current Revenue Per Employee
5994.41
Dividends Per Share - Security
N/A
EBITDA
-90.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.35
Shares Held By Institutions
224M
Shares Outstanding - Current
42.9M
Total Liabilities
25.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
13.740
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com